Taylor, A A <br/><br/>
Sustained hemodynamic effects of the selective dopamine-1 agonist, fenoldopam, during 48-hour infusions in hypertensive patients: a dose-tolerability study.  [electronic resource] 

 -  Journal of clinical pharmacology  May 1999 
 - 471-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0091-2700 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antihypertensive Agents--administration & dosage<br/>Blood Pressure--drug effects<br/>Dopamine Agonists--administration & dosage<br/>Female<br/>Fenoldopam--administration & dosage<br/>Heart Rate--drug effects<br/>Hemodynamics--drug effects<br/>Humans<br/>Hypertension--drug therapy<br/>Infusions, Intravenous<br/>Male<br/>Middle Aged<br/>Pilot Projects<br/>Single-Blind Method